Home
Search
SurgiMabSurgiMab
  • Tumor detection
  • Clinical development
  • Company
    • Team
    • Partners
    • Investors
  • News & Events
  • Contact us
  • Français
SurgiMab is awarded the “Innovative Enterprise” certification from Oseo
  • Tumor detection
  • Clinical development
  • Company
    • Team
    • Partners
    • Investors
  • News & Events
  • Contact us
  • Français
EnglishEnglishFrançaisFrançais

SurgiMab is awarded the “Innovative Enterprise” certification from Oseo

SurgiMab > News & Events > News > SurgiMab is awarded the “Innovative Enterprise” certification from Oseo
18 April 2012 Administrateur SurgiMabLeave a comment0

OSEO, a public institution promoting the innovation and growth of SMEs, awarded SurgiMab the status of Innovative Enterprise and its FCPI certification (Mutual Funds for Innovation) in April.

Previous Post
SurgiMab receives 1 Million € from its investors to bring its first product to the clinic
Next Post
In the press : “SurgiMab to sign a deal with a French CMO…”

Recent Posts

  • SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.
  • SurgiMab will attend the 7th Annual International Congress for Fluorescence-Guided Surgery – Coral Gables, FL, 15th and 16th feb. 2020.
  • SurgiMab sponsors the conference “Molecular-Guided Surgery” of the SPIE Photonics West meeting – San Francisco, 1st and 2nd feb. 2020.
  • SurgiMab announces recruitment of first US patient in pivotal Phase 3 clinical trial evaluating SGM-101 in colorectal cancer patients
  • SurgiMab advances SGM-101 into pivotal Phase 3 clinical trial to improve surgical outcomes in colorectal cancer patients
SurgiMab
Tumor detection Clinical development Company News & Events Contact

About SurgiMab

SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes.

Latest news

  • SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.
  • SurgiMab will attend the 7th Annual International Congress for Fluorescence-Guided Surgery – Coral Gables, FL, 15th and 16th feb. 2020.
Home . Legal & credits
Copyright © 2023 SurgiMab. Website by B-to-B Design